chronic disease management
The two organizations will collaborate to accelerate the company's growth and enhance proactive care and management of chronic diseases.
The company will use the funds to bring its disease management platform to more markets.
It is also expected to offer a new digital weight loss program.
The chronic disease management company also seeks to enter the Middle East and US markets.
DarioHealth buys into MSK with Upright Technologies acquisition and announces $70M private placement
The $31 million purchase will add new capabilities to DarioHealth's condition management and behavior change platform.
The data-driven blood glucose monitor system-maker will use the money to push into new areas of disease management, such as cardiology, oncology and women's health.
Alongside a deeper collaboration with the not-for-profit system, Omada expects the funds to fuel expansion of its integrated digital care program.
The startup is looking to buff up its sales teams with the Series B funding.
The company closed its first day roughly 36% above its initial pricing of $28.
Patients using the platform will be able to share their EHR and medication history with One Drop coaches through the Health Records feature.